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Chapter 8
Residual Confounding Lurking
in Big Data: A Source of Error
John Danziger and Andrew J. Zimolzak
Take Home Messages
• Any observational study may have unidentiﬁed confounding variables that
influence the effects of the primary exposure, therefore we must rely on research
transparency along with thoughtful and careful examination of the limitations to
have conﬁdence in any hypotheses.
• Pathophysiology is complicated and often obfuscates the measured data with
many observations being mere proxies for a physiological process and many
different factors progressing to similar dysfunction.
8.1 Introduction
Nothing is more dangerous than an idea, when you have only one…
—Emile Chartier
Big Data is deﬁned by its vastness, often with large highly granular datasets,
which when combined with advanced analytical and statistical approaches, can
power very convincing conclusions [1]. Herein perhaps lies the greatest challenge
with using big data appropriately: understanding what is not available. In order to
avoid false inferences of causality, it is critical to recognize the influences that
might affect the outcome of interest, yet are not readily measurable.
Given the difﬁculty in performing well-designed prospective, randomized
studies in clinical medicine, Big Data resources such as the Medical Information
Mart for Intensive Care (MIMIC) database [2] are highly attractive. They provide a
powerful resource to examine the strength of potential associations and to test
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whether assumed physiological principles remain robust in clinical medicine.
However, given their often observational nature, causality can not be established,
and great care should be taken when using observational data to influence practice
patterns. There are numerous examples [3, 4] in clinical medicine where observa-
tional data had been used to determine clinical decision making, only to eventually
be disproven, and in the meantime, potentially causing harm. Although associations
may be powerful, missing the unseen connections leads to false inferences. The
unrecognized effect of an additional variable associated with the primary exposure
that influences the outcome of interest is known as confounding.
8.2 Confounding Variables in Big Data
Confounding is often referred to as a “mixing of effects” [5] wherein the effects of
the exposure on a particular outcome are associated with an additional factor,
thereby distorting the true relationship. In this manner, confounding may falsely
suggest an apparent association when no real association exists. Confounding is a
particular threat in observational data, as is often the case with Big Data, due to the
inability to randomize groups to the exposure. The process of randomization
essentially mitigates the influence of unrecognized influences, because these
influences should be nearly equally distributed to the groups. However, more fre-
quently observational data is composed of patient groups that have been distin-
guished based on clinical factors. For example, with critical care observational data,
such as MIMIC, such “non-random allocation” has occurred simply by reaching the
intensive care unit (ICU). There has been some decision process by an admitting
team, perhaps in the Emergency Department, that the patient is ill enough for the
ICU. That decision process is likely influenced by a host of factors, some of which
are identiﬁable, as in blood pressure and severity of illness, and others that are not,
as in “the patient just looks sick” intuition of the provider.
8.2.1 The Obesity Paradox
As an example of the subtlety of this confounding influence, let’s tackle the
question of obesity as a predictor of mortality. In most community-based studies
[6, 7], obesity is associated with poorer outcomes: obese patients have a higher risk
of dying than normal weighted individuals likely mediated by an increased inci-
dence of diabetes, hypertension, and cardiovascular disease. However, amongst
patients admitted to the ICU, obesity is a strong survival beneﬁt [8, 9], with mul-
tiple studies elucidated better outcomes amongst obese critically ill patients than
normal weighted critical ill patients.
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There are potentially many explanations for this paradoxical association. On one
hand, it is plausible that critically ill obese patients have higher nutritional stores
and are better able to withstand the prolonged state of cachexia associated with
critical illness than normal weighted patients. However, let’s explore some other
possibilities. Since obesity is typically deﬁned by the body mass index (BMI) upon
admission to the ICU, it is possible that unrecognized influences on body weight
prior to hospitalization that independently affect outcome might be the true reason
for this paradoxical association. For example, fluid accumulation, as might occur
with congestive heart failure, will increase body weight, but not fat mass, resulting
in an inappropriately elevated BMI. This fluid accumulation, when resulting in
pulmonary edema, is generally considered a marker of illness severity and a war-
rants a higher level of care, such as the ICU. Thus, this fluid accumulation would
prompt the emergency room team to admit the patient to the ICU rather than to the
general medicine ward. Now, heart failure is typically a reasonably treatable disease
process. Diuretics are an effective widely used treatment, and likely can resolve the
speciﬁc factor (i.e. fluid overload) that leads to ICU care. Thus, such a patient
would seem obese, but might not be, and would have a reasonable chance of
survival. Compare that to another such patient, who developed cachexia from
metastatic cancer, and lost thirty pounds prior to presenting to the emergency room.
That patient’s BMI would have dropped signiﬁcantly over the few weeks prior to
illness, and his poor prognosis and illness might lead to an ICU admission, where
his prognosis would be poor. In the latter scenario, concluding that a low BMI was
associated with a poor outcome may not be strictly correct, since it is often rather
the complications of the underlying cancer that lead to mortality.
8.2.2 Selection Bias
Let’s explore one last possibility relating to how the obesity paradox in critical care
might be confounded. Imagine two genetically identical fraternal twins with the
exact same comorbidities and exposures, presenting with cellulitis, weakness, and
diarrhea, both of whom will need frequent cleaning and dressing changes. The only
difference is that one twin has a normal weight, whereas the other is morbidly
obese. Now, the emergency room team must decide which level of care these
patients require. Given the challenges of caring for morbidly obese patient (lifting a
heavy leg, turning to change), it is plausible that obesity itself might influence the
emergency room’s choice regarding disposition. In that case, there would be a
tremendous selection bias. In essence, the obese patient who would have been
generally healthy enough for a general ward ends up in the ICU due to obesity
alone, where the observational data begins. Not surprisingly, that patient will do
better than other ICU patients, since he was healthier in the ﬁrst place and was
admitted simply because he was obese.
Such selection bias, which can be quite subtle, is a challenging problem in
non-randomly allocated studies. Patients groups are often differentiated by their
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illness severity, and thus any observational study assessing the effects of related
treatments may fail to address underlying associated factors. For example, a recent
observational Big Data study attempted to examine whether exposure to proton
pump inhibitors (PPI) was associated with hypomagnesemia [10]. Indeed, in many
thousands of examined patients, PPI users had lower admission serum magnesium
concentrations. Yet, the indication for why the patients were prescribed PPIs in the
ﬁrst place was not known. Plausibly, patients who present with dyspepsia or other
related gastrointestinal symptoms, which are major indications for PPI prescription,
might have lower intake of magnesium-containing foods. Thus, the conclusion that
PPI was responsible for lower magnesium concentrations would be conjecture,
since lower dietary intake would be an equally reasonable explanation.
8.2.3 Uncertain Pathophysiology
In addition to selection bias, as illustrated in the obesity paradox and PPI associated
hypomagnesemia examples, there is another important source of confounding,
particularly in critical care studies. Given that physiology and pathophysiology are
such strong determinants of outcomes in critical illness, the ability to fully account
for the underlying pathophysiologic pathways is extraordinarily important, but also
notoriously difﬁcult. Consider that clinicians caring for patients, standing at the
patient’s bedside in direct examination of all the details, sometimes cannot explain
the physiologic process. Recognizing diastolic heart failure remains challenging.
Accurately characterizing organ function is not straightforward. And if the caring
physician can’t delineate the underlying processes, how can observational data, so
removed from the patient? It can’t, and this is a huge source of potential mistakes.
Let’s consider some examples.
In critical care, the frequent laboratory studies that are easily measured with
precise reproducibility make a welcoming target for cross sectional analysis. In the
literature, almost every common laboratory abnormality has been associated with a
poor outcome, including abnormalities of sodium, potassium, chloride, bicarbonate,
blood urea nitrogen, creatinine, glucose, hemoglobin, etc. Many of these cross
sectional studies have led to management guidelines. The important question
however is whether the laboratory abnormality itself leads to a poor patient out-
come, or whether instead, the underlying patient pathophysiology that leads to the
laboratory abnormality is the primary cause.
Take for example hyponatremia. There is extensive observational data linking
hyponatremia to mortality. In response, there have been extensive treatment
guidelines on how to correct hyponatremia through a combination of water
restriction and sodium administration [11]. However, the mechanistic explanation
for how chronic and/or mild hyponatremia might cause a poor outcome is not
totally convincing. Some data might suggest that potential subtle cerebral edema
might lead to imbalance and falls, but this is not a completely convincing expla-
nation for the association of admission hyponatremia with in-hospital death.
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Many cross-sectional studies have not addressed the underlying reason for
hyponatremia in the ﬁrst place. Most often, hyponatremia is caused by sensed
volume depletion, as might occur in liver disease and heart disease. Sensed volume
is a concept describing the body’s internal measure of intravascular volume, which
directly affects the body’s sodium avidity, and which under certain conditions
affects its water avidity. Sensed volume is quite difﬁcult to determine clinically, and
there are no billing or diagnostic codes to describe it. Therefore, even though sensed
volume is the strongest determinant of serum sodium concentrations in large
population studies, it is not a capturable variable, and thus it cannot be included as a
covariate in adjusted analyses. Its absence likely leads to false conclusions. As of
now, despite a plethora of studies showing that hyponatremia is associated with
poor outcomes, we collectively can not conclude whether it is the water excess
itself, or the underlying cardiac or liver pathophysiologic abnormalities that cause
the hyponatremia, that is of greater importance.
Let us consider another very important example. There have been a plethora of
studies in the critical care literature linking renal function to a myriad of outcomes
[12, 13]. One undisputed conclusion is that impaired renal function is associated
with increased cardiovascular mortality, as illustrated in Fig. 8.1.
However, this association is really quite complex, with a number of important
confounding issues that undermine this conclusion. The ﬁrst issue is how accurately
a serum creatinine measurement reflects the glomerular ﬁltration rate (GFR).
Calculations such as the Modiﬁcation of Diet in Renal Disease (MDRD) equation
were developed as epidemiologic tools to estimate GFR [14] but do not accurately
deﬁne underlying renal physiology. Furthermore, even if one considers the serum
creatinine as a measure of GFR, there are multiple other aspects of kidney functions
beyond the GFR, including sodium and fluid balance, erythropoietin and activated
vitamin D production, and tubular function, none of which are easily measurable,
and thus cannot be accounted for.
However, in addition to confounding due to an inability to accurately charac-
terize “renal function,” signiﬁcant residual confounding due to unaccounted
pathophysiology is equally problematic. In relation to the association of renal
function with cardiovascular mortality, there are many determinants of cardiac
function that simultaneously and independently influence both the serum creatinine
Fig. 8.1 Concept map of the association of kidney function, as determined by the glomerular
ﬁltration rate, as a determinant of cardiovascular morality
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concentration and cardiovascular outcomes. For example, increased jugular venous
pressures are a strong determinant of cardiac outcome and influence renal function
through renal vein congestion. Cardiac output, pulmonary artery pressures, and
activation of the renin-angiotensin-aldosterone axis also likely influence both renal
function and cardiac outcomes. The concept map is likely more similar to Fig. 8.2.
Since many of these variables are rarely measured or quantiﬁed in large epi-
demiologic studies, signiﬁcant residual confounding likely exists, and potential bias
by failing to appreciate the complexity of the underlying pathophysiology is likely.
Multiple statistical techniques have been developed to account for residual
confounding to non-randomization and to underlying severity of illness in critical
care. Propensity scores, which attempt to better capture the factors that lead to the
non-randomized allocation (i.e. the factors which influence the decision to admit to
the ICU or to expose to a PPI) are used widely to minimize selection bias [15].
Adjustment using variables that attempt to capture severity of illness, such as the
Simpliﬁed Acute Physiology Score (SAPS) [16], or the Sequential/ Sepsis-related
Organ Failure Assessment (SOFA) score [17], or comorbidity adjustment scores,
such as Charlson or Elixhauser [18, 19], remain imprecise, as does risk adjustment
with area under the receiver operating characteristic curve (AUROC). Ultimately,
signiﬁcant confounding cannot be adjusted away by the most sophisticated statis-
tical techniques, and thoughtful and careful examination of the limitations of any
observational study must be transparent.
Fig. 8.2 Concept map of the association of renal function and cardiovascular mortality revealing
more of the confounding influences
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8.3 Conclusion
In summary, tread gently when harvesting the power of Big Data, for what is not
seen is exactly what may be of most interest. Be clear about the limitations of using
observational data, and suggest that most observational studies are hypothesis
generating and require more well designed studies to better address the question at
hand.
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